15-LOX-2, in contrast, prefers AA over LA, makes mainly the AA metabolite, 15-hydroxy-eicosatetraenoic acid (15-HETE), is under-expressed or absent in prostate cancer, and its levels correlate negatively with disease severity [14], [17], [18], [19], [20]. Here, ALOX15B is linked to prostate cancer.